MetaCap

K2 Capital Acquisition (KTWO) vs Profound Medical (PROF)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Profound Medical is the larger company by market cap ($249.9 million vs $201.8 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

KTWO+2.03%PROF-26.95%
+10%-14%-37%
Feb 26, 20261 yearOct 7, 2026
KTWO+2.13%PROF-25.36%
+4%-16%-35%
Feb 23, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

KTWO versus PROF key metrics
MetricKTWOPROF
Share price$10.07$6.84
Market cap$201.81M$249.94M
1-day change0.00%+20.42%
YTD return—-27.83%
1-year return—-12.07%
5-year return—-62.16%
EPS (TTM)—$-0.99
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$10.10$8.95
52-week low$9.84$4.80
Distance from 52-week high-0.30%-23.58%
Analyst consensus—none
Avg. price target upside—+62.87%
Average volume29.99K124.80K
Shares outstanding14.13M36.54M
Employees—162
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About K2 Capital Acquisition

KTWO stock →

K2 Capital Acquisition Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the physical AI or energy transition sectors.

Health Care · Medical/Dental Instruments

About Profound Medical

PROF stock →

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.

Health Care · Medical/Dental Instruments · 162 employees

KTWO vs PROF FAQ

Which is bigger, K2 Capital Acquisition or Profound Medical?

Profound Medical (PROF) is larger, with a market capitalization of $249.94M compared with $201.81M for K2 Capital Acquisition (KTWO).

Are K2 Capital Acquisition and Profound Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons